These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4276536)

  • 1. Proceedings: Quantitative investigations of drug hydroxylating enzymes of the liver using model substrates.
    Dünges W; Heinemann H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R17. PubMed ID: 4276536
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of hepatic drug metabolism.
    Homeida H
    East Afr Med J; 1979 Feb; 56(2):80-3. PubMed ID: 394954
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fundamentals of drug metabolism].
    Netter KJ
    Arzneimittelforschung; 1972 Feb; 22(2):285-92. PubMed ID: 4402072
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of drugs and poisons on the synthesis and activity of microsomal enzymes participating in their metabolism].
    Hanke J
    Folia Med Cracov; 1980; 22(3-4):263-78. PubMed ID: 7026384
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: On the measurement of different microsomal hydroxylating activities after pretreatment with several barbiturates.
    Dünges W; Heinemann H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R78. PubMed ID: 1143495
    [No Abstract]   [Full Text] [Related]  

  • 6. Polyamines and drug oxidations.
    Chapman SK
    Drug Metab Dispos; 1976; 4(5):417-22. PubMed ID: 10139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: The effect of triiodinated radiographic contrast media on microsomal drug metabolism.
    Hüthwohl B; Hohage H; Trüber E
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R79. PubMed ID: 1143497
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacotherapy for reduced activity of microsomal liver enzymes (review of the literature)].
    Chekman IS; Grinevich AI
    Vrach Delo; 1988 Jan; (1):24-8. PubMed ID: 3284200
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic capabilities of the human fetus: drug biotransformation.
    Juchau MR
    Addict Dis; 1975; 2(1-2):37-43. PubMed ID: 1163372
    [No Abstract]   [Full Text] [Related]  

  • 10. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
    Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: The effect of cysteamine on the microsomal drug metabolism system.
    Mull RH; Gertz J; Flemming K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R69. PubMed ID: 4276621
    [No Abstract]   [Full Text] [Related]  

  • 12. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O; Yano Y
    Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward a bioartificial drug metabolizing system: gel immobilized liver cell microsomes.
    Denti E; Freston JW; Marchisio M; Kolff WJ
    Trans Am Soc Artif Intern Organs; 1976; 22():693-700. PubMed ID: 951889
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibilities of evaluating the activity of the drug biotransformation system in clinical pharmacology].
    Zolotareva TA
    Farmakol Toksikol; 1987; 50(3):121-6. PubMed ID: 3301398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic metabolism of foreign substances. Enzymatic hydroxylation system of hepatic microsomes and of cytochrome P-450].
    Valla D
    Med Chir Dig; 1978; 7(3):259-62, 265-6. PubMed ID: 28455
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the Prethcamide hydroxylation system in rat hepatic microsomes.
    Szumiło T; Bryła P; Byra A
    Acta Biochim Pol; 1984; 31(4):409-19. PubMed ID: 6543484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation.
    Singh G; Renton KW
    Mol Pharmacol; 1981 Nov; 20(3):681-4. PubMed ID: 6173738
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes.
    Chang TK; Weber GF; Crespi CL; Waxman DJ
    Cancer Res; 1993 Dec; 53(23):5629-37. PubMed ID: 8242617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics].
    Cahen R
    Eur J Toxicol Hyg Environ; 1972; Suppl 3():67-80. PubMed ID: 4157455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.